adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo]

RxCUI: 2668204
RxNorm name: adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo]
Display name: adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo]
Full name: adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cabtreo	CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE	Bausch Health US LLC	9468da0f-9978-4c58-8135-0274c3415084	2025-04-24	Warnings, Adverse reactions	Exact identifier rxcui: 2668204

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
9468da0f-9978-4c58-8135-0274c3415084	adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo]	SBD	6	These highlights do not include all the information needed to use CABTREO safely and effectively. See full prescribing information for CABTREO. CABTREO ® (clindamycin phosphate, adapalene, and benzoyl peroxide) topical gel Initial U.S. Approval: 2023	20250424
9468da0f-9978-4c58-8135-0274c3415084	Cabtreo (adapalene 0.15 % / benzoyl peroxide 3.1 % / clindamycin phosphate 1.2 % ) Topical Gel	SY	6	These highlights do not include all the information needed to use CABTREO safely and effectively. See full prescribing information for CABTREO. CABTREO ® (clindamycin phosphate, adapalene, and benzoyl peroxide) topical gel Initial U.S. Approval: 2023	20250424
9468da0f-9978-4c58-8135-0274c3415084	CABTREO 1.2 % / 0.15 % / 3.1 % Topical Gel	PSN	6	These highlights do not include all the information needed to use CABTREO safely and effectively. See full prescribing information for CABTREO. CABTREO ® (clindamycin phosphate, adapalene, and benzoyl peroxide) topical gel Initial U.S. Approval: 2023	20250424